Positioning amivantamab and lazertinib in the therapeutic sequence for -mutant NSCLC: insights from CHRYSALIS-2 cohort A.
作者信息
Abodunrin Faith, Berlin Dillon E, Bestvina Christine M
机构信息
Section of Hematology/Oncology, Division of Medicine, University of Chicago Medicine, Chicago, IL, USA.
出版信息
Transl Lung Cancer Res. 2025 Aug 31;14(8):2906-2911. doi: 10.21037/tlcr-2025-461. Epub 2025 Aug 14.
Abstract
摘要
Zotero 插件